AwardedDNKGoodsFramework agreementDKK 60,400,000
Amgros 2027 1.1577.a
- Published
- Published 13 May 2026
- Deadline
- Closed 22 June 2026
Overview
Amgros I/S, a joint venture owned by Denmark's five regions, has awarded framework agreements for pharmaceutical supply to regional hospital pharmacies and potentially to the Faroe Islands and Greenland. The award, valued at approximately 20.1 million DKK, was granted on 6 July 2026 to three suppliers: 2care4 ApS, Merck A/S, and Orifarm A/S. The non-exclusive framework agreements operate without minimum purchase obligations, allowing hospital pharmacies to choose whether to use Amgros' agreements.
Key details
- Country
- DNK
- Status
- Awarded
- Category
- Goods
- Estimated value
- DKK 60,400,000
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 13 May 2026
- Deadline
- Closed
Pharmaceutical products
Award outcome
- Awarded value
- DKK 20,133,333
- Award date
- 6 July 2026
- Contract period
- 1 January 2027 → 31 December 2028
- 2care4 ApS
- Merck A/S
- Orifarm A/S
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
7 July 2026
Contract Notice
12 May 2026
Contracting authority
Amgros I/S
Procuring entityKøbenhavn Ø, DNK
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.